Practical solutions to addressing social determinants of health in the ambulatory care setting. Listen in your browser or podcast app of choice; continuing medical education credit available.

The genetic mutation that causes Huntington’s disease, a devastating brain disease that disrupts mobility and diminishes cognitive ability, may also enhance early brain development and play a role in promoting human intelligence. “The finding suggests that early in life, the gene mutation is actually beneficial to brain development, but that early benefit later becomes a liability,” says Peg Nopoulos, MD, professor and head of psychiatry at the UI Carver College of Medicine.

The University of Iowa Roy J. and Lucille A. Carver College of Medicine is pleased to announce the 2024 cohort of the Stead Family Scholars Program. The goal of this program is to recognize and advance the development of outstanding early-career faculty who are becoming internationally recognized leaders in their respective fields of research.

Alumna Maria Story is innovating health care delivery in southeast Iowa with a keen focus on quality of life for dialysis patients.

James Byrne, MD, PhD, assistant professor of radiation oncology at University of Iowa Health Care, has been awarded the prestigious 2024 NIH Director’s New Innovator Award, recognizing his groundbreaking work aimed at improving outcomes and quality of life for cancer patients undergoing radiation therapy. Byrne is one of 40 early career scientists across the nation to receive this award, which is part of the NIH Common Fund's High-Risk, High-Reward Research Program that supports exceptionally innovative research projects led by early career investigators.

The award recognizes Paul McCray Jr., MD, for his pioneering work in gene therapies and dedication to the final 10% of the cystic fibrosis community who do not benefit from current CFTR modulators.

Kathy Edwards (73MD) is a world-renowned physician, teacher, mentor, and researcher who has made significant contributions to life-saving advances in vaccines. Throughout her career, she has designed and executed clinical trials and educated others on their conduct to ensure the safety and efficacy of vaccines for influenza, pertussis, pneumococcus, and many other pathogens. Edwards is a recipient of the University of Iowa Center for Advancement's 2024 Achievement Award.

Jon Lensing (20MD) co-founded OpenLoop in 2019, when he was a medical student at the University of Iowa. As CEO of the telehealth company, he has applied his leadership, research, and technology skills to grow the company nationwide with the vision to bring healing anywhere. Lensing is a recipient of the University of Iowa Center for Advancement's 2024 Recent Graduate Award.

John Callaghan, MD (83R) is a leading expert in hip and knee surgery with hundreds of research and grant credits. Driven by a continual pursuit of knowledge at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, Callaghan dedicated himself as a faculty member, volunteer, and role model to make a positive global impact in his field. Callaghan is a recipient of the University of Iowa Center for Advancement's 2024 Faculty Award.

The clinical trial of benfotiamine is currently recruiting people with early Alzheimer’s disease.